ArticleHaematologica2022

Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort study.

Ron Ram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.